Structures by: Perlovich G. L.
Total: 135
C7H6O3,C7H7NO2
C7H6O3,C7H7NO2
The journal of physical chemistry. B (2015) 119, 33 10466-10477
a=13.8869(5)Å b=8.01874(18)Å c=12.8184(4)Å
α=90.00° β=115.187(4)° γ=90.00°
C7H7NO3,C7H7NO2
C7H7NO3,C7H7NO2
The journal of physical chemistry. B (2015) 119, 33 10466-10477
a=32.1000(15)Å b=4.1188(2)Å c=9.6966(4)Å
α=90.00° β=90.00° γ=90.00°
C14H11Cl2NO2,C7H8N4O2
C14H11Cl2NO2,C7H8N4O2
Molecular pharmaceutics (2014) 11, 10 3707-3715
a=7.525(3)Å b=12.138(4)Å c=12.231(4)Å
α=73.505(6)° β=80.547(6)° γ=80.693(6)°
C13H8F2O3,C7H8N4O2
C13H8F2O3,C7H8N4O2
Molecular pharmaceutics (2014) 11, 10 3707-3715
a=7.0731(4)Å b=35.014(2)Å c=7.6856(4)Å
α=90.00° β=100.827(1)° γ=90.00°
C16H16N2O5
C16H16N2O5
The journal of physical chemistry. B (2014) 118, 24 6803-6814
a=10.838(5)Å b=11.225(5)Å c=13.268(6)Å
α=90.00° β=107.879(7)° γ=90.00°
C11H12ClN3OS
C11H12ClN3OS
The journal of physical chemistry. B (2013) 117, 36 10414-10429
a=8.7382(14)Å b=11.7601(18)Å c=11.8741(19)Å
α=90.00° β=99.503(2)° γ=90.00°
C12H14ClN3OS
C12H14ClN3OS
The journal of physical chemistry. B (2013) 117, 36 10414-10429
a=7.515(3)Å b=12.070(5)Å c=15.831(7)Å
α=70.379(7)° β=78.224(7)° γ=74.463(7)°
C12H15N3O1S1
C12H15N3O1S1
The journal of physical chemistry. B (2013) 117, 36 10414-10429
a=8.6335(2)Å b=14.1307(3)Å c=21.2871(5)Å
α=90° β=90° γ=90°
C11H12Cl1N3O1S1
C11H12Cl1N3O1S1
The journal of physical chemistry. B (2013) 117, 36 10414-10429
a=12.606(8)Å b=12.807(8)Å c=7.633(7)Å
α=90° β=90.590(3)° γ=90°
C12H14Cl1N3O1S1
C12H14Cl1N3O1S1
The journal of physical chemistry. B (2013) 117, 36 10414-10429
a=9.4374(3)Å b=13.0463(4)Å c=22.2127(6)Å
α=90° β=90° γ=90°
C4H6N4O3S2,C7H7N1O2
C4H6N4O3S2,C7H7N1O2
Physical chemistry chemical physics : PCCP (2020) 22, 36 20867-20879
a=28.8618(14)Å b=7.5904(4)Å c=14.3121(7)Å
α=90.00° β=104.3061(7)° γ=90.00°
1:1 Cocrystal of Olanzapine and Resorcinol
C17H20N4S,C6H6O2
CrystEngComm (2020)
a=9.3190(5)Å b=11.5430(7)Å c=19.5648(12)Å
α=90° β=90.064(3)° γ=90°
1:1 Cocrystal of Olanzapine and Catechol
C17H20N4S,C6H6O2
CrystEngComm (2020)
a=25.972(5)Å b=9.1477(16)Å c=19.595(4)Å
α=90° β=107.679(8)° γ=90°
1:1:1 Cocrystal of Olanzapine, Hydroquinone and Benzene
C17H20N4S,C6H6O2,C6H6
CrystEngComm (2020)
a=9.0547(18)Å b=10.719(2)Å c=14.236(3)Å
α=80.860(5)° β=82.955(6)° γ=84.355(6)°
1:1:1 Cocrystal of Olanzapine, Hydroquinone and pXylene
C17H20N4S,C6H6O2,C8H10
CrystEngComm (2020)
a=9.3159(3)Å b=10.3802(4)Å c=15.0112(5)Å
α=96.2211(14)° β=90.7786(13)° γ=98.1870(13)°
1:1:2 Cocrystal of Olanzapine, Hydroquinone and Benzene
C17H20N4S,C6H6O2,2(C6H6)
CrystEngComm (2020)
a=9.1116(5)Å b=10.7195(7)Å c=15.8385(9)Å
α=88.452(2)° β=87.7422(17)° γ=82.8273(19)°
1:1:1:2 Cocrystal of Olanzapine, Hydroquinone, pXylene and Water
C17H20N4S,0.5(C6H6O2),0.5(C8H10),2(H2O)
CrystEngComm (2020)
a=28.1714(17)Å b=12.6444(7)Å c=14.0673(8)Å
α=90° β=104.3974(19)° γ=90°
1:1:1 Cocrystal of Olanzapine, Hydroquinone and Ethylbenzene
C17H20N4S,C6H6O2,C8H10
CrystEngComm (2020)
a=9.2694(12)Å b=10.3353(13)Å c=14.9174(19)Å
α=89.159(4)° β=86.632(4)° γ=82.387(4)°
C17H19FN3O3,C7H6NO2,H2O
C17H19FN3O3,C7H6NO2,H2O
CrystEngComm (2020)
a=21.457(2)Å b=14.4489(15)Å c=7.3700(8)Å
α=90.00° β=90.013(2)° γ=90.00°
C17H19FN3O3,C7H5O5,2.167(H2O)
C17H19FN3O3,C7H5O5,2.167(H2O)
CrystEngComm (2020)
a=9.1210(7)Å b=27.264(2)Å c=10.3393(8)Å
α=90.00° β=93.365(1)° γ=90.00°
C13H12N3O2,C7H4NO3S
C13H12N3O2,C7H4NO3S
New J. Chem. (2015) 39, 11 8614
a=6.1217(11)Å b=24.779(5)Å c=12.246(2)Å
α=90.00° β=98.345(3)° γ=90.00°
C14H14N3O3,C7H4NO3S
C14H14N3O3,C7H4NO3S
New J. Chem. (2015) 39, 11 8614
a=6.1904(9)Å b=26.105(4)Å c=12.4015(18)Å
α=90.00° β=100.464(2)° γ=90.00°
C19H27NO3S
C19H27NO3S
CrystEngComm (2020) 22, 2 349-360
a=10.5390(3)Å b=15.4431(4)Å c=11.3497(3)Å
α=90° β=105.2140(10)° γ=90°
C19H24F3NO2S
C19H24F3NO2S
CrystEngComm (2020) 22, 2 349-360
a=9.4774(4)Å b=12.9160(6)Å c=15.3582(7)Å
α=90° β=99.8470(10)° γ=90°
C18H24N2O4S
C18H24N2O4S
CrystEngComm (2020) 22, 2 349-360
a=14.9094(6)Å b=12.1019(5)Å c=10.5363(5)Å
α=90° β=107.7580(10)° γ=90°
C20H28N2O3S
C20H28N2O3S
CrystEngComm (2020) 22, 2 349-360
a=19.645(4)Å b=15.735(3)Å c=14.349(3)Å
α=90° β=114.347(7)° γ=90°
C20H28N2O3S
C20H28N2O3S
CrystEngComm (2020) 22, 2 349-360
a=18.8607(8)Å b=15.5920(7)Å c=14.1742(6)Å
α=90° β=109.2060(10)° γ=90°
C19H24F3NO3S
C19H24F3NO3S
CrystEngComm (2020) 22, 2 349-360
a=10.5361(6)Å b=11.2474(6)Å c=16.3452(10)Å
α=90° β=100.077(2)° γ=90°
C18H24N2O3S
C18H24N2O3S
CrystEngComm (2020) 22, 2 349-360
a=12.0138(6)Å b=12.6480(6)Å c=13.5487(7)Å
α=107.167(2)° β=111.066(2)° γ=97.215(2)°
C19H27N1O2S1
C19H27N1O2S1
CrystEngComm (2020) 22, 2 349-360
a=6.6214(14)Å b=10.2453(17)Å c=13.391(2)Å
α=91.638(14)° β=96.140(17)° γ=100.447(16)°
C17H20F3NO3S
C17H20F3NO3S
CrystEngComm (2020) 22, 2 349-360
a=11.0788(5)Å b=12.2658(6)Å c=12.9608(6)Å
α=90° β=108.4380(10)° γ=90°
C20H28N2O3S
C20H28N2O3S
CrystEngComm (2020) 22, 2 349-360
a=19.5823(13)Å b=15.6900(10)Å c=14.2997(10)Å
α=90° β=114.189(2)° γ=90°
C18H24N2O3S,2(H2O)
C18H24N2O3S,2(H2O)
CrystEngComm (2020) 22, 2 349-360
a=13.3372(6)Å b=6.7727(3)Å c=21.8857(10)Å
α=90° β=101.262(2)° γ=90°
C21H31NO2S
C21H31NO2S
CrystEngComm (2020) 22, 2 349-360
a=10.5236(3)Å b=13.9711(4)Å c=14.1761(4)Å
α=78.4410(10)° β=85.2520(10)° γ=73.4320(10)°
C17H20F3NO2S
C17H20F3NO2S
CrystEngComm (2020) 22, 2 349-360
a=11.0703(5)Å b=12.2683(5)Å c=13.2315(6)Å
α=107.558(2)° β=90.903(2)° γ=102.794(2)°
C13H11ClN2O2,C5H9NO2
C13H11ClN2O2,C5H9NO2
CrystEngComm (2018) 20, 43 6970
a=5.7721(7)Å b=12.3373(15)Å c=24.977(3)Å
α=90.00° β=90.00° γ=90.00°
C13H9F3N2O2,C5H9NO2
C13H9F3N2O2,C5H9NO2
CrystEngComm (2018) 20, 43 6970
a=11.8073(17)Å b=5.8122(8)Å c=13.3488(19)Å
α=90.00° β=97.844(2)° γ=90.00°
C14H11Cl2NO2,C5H9NO2
C14H11Cl2NO2,C5H9NO2
CrystEngComm (2018) 20, 43 6970
a=9.2716(9)Å b=5.2277(5)Å c=20.3473(19)Å
α=90.00° β=102.235(1)° γ=90.00°
C7H7NO2,C7H7NO2
C7H7NO2,C7H7NO2
CrystEngComm (2019) 21, 13 2119
a=26.744(2)Å b=3.8660(3)Å c=24.352(2)Å
α=90.00° β=90.00° γ=90.00°
C8H12NO,C7H6NO2
C8H12NO,C7H6NO2
CrystEngComm (2019) 21, 13 2119
a=12.8319(9)Å b=11.6670(8)Å c=9.5936(7)Å
α=90.00° β=90.00° γ=90.00°
C7H7NO2,C7H7NO2
C7H7NO2,C7H7NO2
CrystEngComm (2019) 21, 13 2119
a=3.9358(5)Å b=15.944(2)Å c=20.680(3)Å
α=90.00° β=90.305(2)° γ=90.00°
C7H7NO2,C4H4N2O3
C7H7NO2,C4H4N2O3
CrystEngComm (2019) 21, 13 2119
a=7.6177(5)Å b=6.5936(4)Å c=22.5748(14)Å
α=90.00° β=97.516(1)° γ=90.00°
C7H7NO2,C5H6N2O2
C7H7NO2,C5H6N2O2
CrystEngComm (2019) 21, 13 2119
a=10.1018(5)Å b=11.3577(5)Å c=21.6477(10)Å
α=90.00° β=98.4472(7)° γ=90.00°
C11H12ClN3OS,C7H6O5,H2O
C11H12ClN3OS,C7H6O5,H2O
Physical chemistry chemical physics : PCCP (2018) 20, 21 14469-14481
a=9.6276(8)Å b=10.1883(8)Å c=11.0539(9)Å
α=90.533(1)° β=100.803(1)° γ=105.940(1)°
C18H24ClNO2S
C18H24ClNO2S
CrystEngComm (2018) 20, 25 3476
a=10.3869(3)Å b=15.4759(3)Å c=11.2824(3)Å
α=90° β=105.723(3)° γ=90°
C16H20BrNO2S
C16H20BrNO2S
CrystEngComm (2018) 20, 25 3476
a=11.0548(8)Å b=6.4659(4)Å c=21.6540(14)Å
α=90° β=102.382(2)° γ=90°
C18H24N2O4S
C18H24N2O4S
CrystEngComm (2018) 20, 25 3476
a=10.5834(3)Å b=15.2084(5)Å c=11.6137(3)Å
α=90° β=107.1010(10)° γ=90°
C19H24F3NO2S
C19H24F3NO2S
CrystEngComm (2018) 20, 25 3476
a=10.7288(4)Å b=15.5406(6)Å c=11.6218(5)Å
α=90° β=106.4540(10)° γ=90°
C18H24BrNO2S
C18H24BrNO2S
CrystEngComm (2018) 20, 25 3476
a=10.5014(3)Å b=15.4718(4)Å c=11.3326(3)Å
α=90° β=106.420(3)° γ=90°
C17H20F3NO2S
C17H20F3NO2S
CrystEngComm (2018) 20, 25 3476
a=29.081(2)Å b=6.8576(6)Å c=19.1376(16)Å
α=90° β=123.701(2)° γ=90°
C16H20N2O4S
C16H20N2O4S
CrystEngComm (2018) 20, 25 3476
a=11.0672(8)Å b=6.4621(5)Å c=21.5494(16)Å
α=90° β=103.132(2)° γ=90°
0.5(C14H12O6),2(C4H3FN2O2)
0.5(C14H12O6),2(C4H3FN2O2)
CrystEngComm (2019) 21, 34 5095
a=14.5354(8)Å b=6.9178(4)Å c=15.7237(8)Å
α=90° β=96.902(5)° γ=90°
C17H19FN3O3,C4H3O4,0.155(H2O)
C17H19FN3O3,C4H3O4,0.155(H2O)
CrystEngComm (2018) 20, 6 755
a=8.0133(9)Å b=37.244(4)Å c=6.9698(8)Å
α=90.00° β=92.806(2)° γ=90.00°
2(C16H19FN3O3),C4H2O4,2(H2O)
2(C16H19FN3O3),C4H2O4,2(H2O)
CrystEngComm (2018) 20, 6 755
a=6.7869(4)Å b=9.3544(6)Å c=15.7300(9)Å
α=93.6351(9)° β=92.6297(9)° γ=110.9168(9)°
C16H19FN3O3,C4H3O4,2(H2O)
C16H19FN3O3,C4H3O4,2(H2O)
CrystEngComm (2018) 20, 6 755
a=8.1127(8)Å b=9.6281(9)Å c=27.380(3)Å
α=90.00° β=93.525(2)° γ=90.00°
Felodipine:acetone (1:1)
C18H19Cl2NO4,C3H6O
CrystEngComm (2015) 17, 22 4089
a=9.1774(8)Å b=16.6983(15)Å c=14.3375(11)Å
α=90° β=105.865(4)° γ=90°
Felodipine:acetophenone (1:1)
C18H19Cl2NO4,C8H8O
CrystEngComm (2015) 17, 22 4089
a=7.3940(7)Å b=11.4991(10)Å c=29.003(2)Å
α=90.00° β=90.00° γ=90.00°
Felodipine:dimethylsulfoxide (1:1)
C18H19Cl2NO4,C2H6OS
CrystEngComm (2015) 17, 22 4089
a=8.660(3)Å b=9.816(3)Å c=13.782(4)Å
α=87.37(2)° β=79.17(3)° γ=77.79(3)°
C15H12N2O,C7H7NO3
C15H12N2O,C7H7NO3
CrystEngComm (2017)
a=27.427(5)Å b=7.6402(15)Å c=21.038(4)Å
α=90.00° β=119.263(2)° γ=90.00°
2(C15H12N2O),C7H7NO3,CH4O
2(C15H12N2O),C7H7NO3,CH4O
CrystEngComm (2017)
a=12.6443(18)Å b=7.5232(11)Å c=34.674(5)Å
α=90.00° β=96.811(3)° γ=90.00°
C18H14F4N2O4S,C7H7NO
C18H14F4N2O4S,C7H7NO
CrystEngComm (2016) 18, 25 4818
a=5.7985(11)Å b=11.964(3)Å c=17.496(3)Å
α=101.978(7)° β=97.828(7)° γ=90.114(8)°
C18H14F4N2O4S,C7H7NO2
C18H14F4N2O4S,C7H7NO2
CrystEngComm (2016) 18, 25 4818
a=5.8888(3)Å b=21.5969(11)Å c=19.2814(10)Å
α=90° β=97.821(2)° γ=90°
2(C15H12N2O),C7H7NO3,H2O
2(C15H12N2O),C7H7NO3,H2O
CrystEngComm (2017)
a=13.6727(12)Å b=17.6172(15)Å c=14.8361(13)Å
α=90.00° β=116.334(1)° γ=90.00°
Felodipine : N,N-dimethylacetamide (1:1)
C18H19Cl2NO4,C4H9NO
CrystEngComm (2013) 15, 30 6054
a=9.1075(4)Å b=15.7970(7)Å c=16.6894(7)Å
α=90.00° β=105.699(1)° γ=90.00°
Felodipine : 1,3-dimethylimidazolidine-2-one (1:1)
C18H19Cl2NO4,C5H10N2O
CrystEngComm (2013) 15, 30 6054
a=28.6544(12)Å b=11.4450(5)Å c=14.5730(6)Å
α=90.00° β=90.715(1)° γ=90.00°
Felodipine : tetramethylurea (1:1)
C18H19Cl2NO4,C5H12N2O
CrystEngComm (2013) 15, 30 6054
a=16.3261(18)Å b=11.4866(11)Å c=14.7468(17)Å
α=90.00° β=111.959(3)° γ=90.00°
N-Adamantan-1-yl-4-methyl-benzenesulfonamide
C17H23NO2S
CrystEngComm (2015) 17, 4 753
a=11.189(2)Å b=6.5360(13)Å c=21.527(4)Å
α=90.00° β=102.41(3)° γ=90.00°
N-Adamantan-1-yl-benzenesulfonamide
C16H21NO2S
CrystEngComm (2015) 17, 4 753
a=11.9770(10)Å b=10.5160(10)Å c=11.2900(10)Å
α=90.00° β=90.00° γ=90.00°
N-Adamantan-1-yl-4-chloro-benzenesulfonamide
C16H20ClNO2S
CrystEngComm (2015) 17, 4 753
a=11.0510(4)Å b=6.4458(3)Å c=21.4660(8)Å
α=90.00° β=102.427(3)° γ=90.00°
N-(3,5-Dimethyl-adamantan-1-yl)-4-fluoro-benzenesulfonamide
C18H24FNO2S
CrystEngComm (2015) 17, 4 753
a=10.5261(3)Å b=11.5499(3)Å c=14.1017(4)Å
α=90.00° β=97.386(2)° γ=90.00°
N-(3,5-Dimethyl-adamantan-1-yl)-4-methyl-benzenesulfonamide
C19H27NO2S
CrystEngComm (2015) 17, 4 753
a=10.8028(3)Å b=11.6083(3)Å c=14.0725(4)Å
α=90.00° β=95.824(3)° γ=90.00°
N-(3,5-Dimethyl-adamantan-1-yl)-benzenesulfonamide
C18H25NO2S
CrystEngComm (2015) 17, 4 753
a=9.33501(18)Å b=11.5770(2)Å c=15.7703(3)Å
α=90.00° β=100.5871(18)° γ=90.00°
Felodipine : 4,4'-bipyridine (1:1)
C18H19Cl2NO4,C10H8N2
CrystEngComm (2014) 16, 29 6603
a=7.7589(10)Å b=9.2634(12)Å c=17.830(2)Å
α=90.403(8)° β=90.275(9)° γ=97.322(9)°
Felodipine : 4,4'-bipyridine (1:1)
C18H19Cl2NO4,C10H8N2
CrystEngComm (2014) 16, 29 6603
a=36.197(3)Å b=36.436(3)Å c=8.0228(6)Å
α=90° β=90° γ=90°
C12H15N3O2S
C12H15N3O2S
The journal of physical chemistry. B (2013) 117, 36 10414-10429
a=11.299(3)Å b=7.254(2)Å c=15.444(5)Å
α=90.00° β=101.681(5)° γ=90.00°
Emoxypinium maleate
C8H12NO,C4H3O4
Acta Crystallographica Section C (2018) 74, 7
a=26.571(3)Å b=6.9074(8)Å c=13.5152(16)Å
α=90.00° β=90.00° γ=90.00°
Emoxypinium adipate
C8H12NO,C6H9O4
Acta Crystallographica Section C (2018) 74, 7
a=8.7831(17)Å b=8.9442(17)Å c=9.6114(18)Å
α=77.301(3)° β=76.142(3)° γ=85.677(3)°
C14H15F3N2S
C14H15F3N2S
Acta Crystallographica Section B (2014) 70, 1 47-53
a=13.074(8)Å b=9.185(5)Å c=12.652(8)Å
α=90.00° β=109.33(6)° γ=90.00°
C13H15FN2S
C13H15FN2S
Acta Crystallographica Section B (2014) 70, 1 47-53
a=7.5860(10)Å b=10.088(2)Å c=16.566(4)Å
α=90.00° β=91.41(3)° γ=90.00°
C14H18N2S
C14H18N2S
Acta Crystallographica Section B (2014) 70, 1 47-53
a=8.7377(2)Å b=14.1088(3)Å c=20.8300(5)Å
α=90.00° β=90.00° γ=90.00°
4-Carboxyanilinium pyrazine-2-carboxylate
C7H8NO2,C5H3N2O2
Acta Crystallographica Section E (2018) 74, 12 1923-1927
a=5.95233(16)Å b=3.80345(11)Å c=25.6879(7)Å
α=90° β=95.037(2)° γ=90°
N-(4-Chlorophenyl)benzenesulfonamide
C12H10ClNO2S
Acta Crystallographica Section E (2006) 62, 1 o376-o378
a=10.840(2)Å b=9.7400(10)Å c=23.596(3)Å
α=90.00° β=90.00° γ=90.00°
P-ethoxyacetanilide
C10H13NO2
Acta Crystallographica Section E (2006) 62, 7 o2712-o2713
a=13.3236(14)Å b=9.6159(15)Å c=7.7331(15)Å
α=90.00° β=103.992(14)° γ=90.00°
(+)-ibuprofen
C13H18O2
Acta Crystallographica Section E (2006) 62, 7 e17-e18
a=12.456(4)Å b=8.0362(11)Å c=13.533(3)Å
α=90.00° β=112.86(2)° γ=90.00°
N-(2-Chlorophenyl)benzenesulfonamide
C12H10ClNO2S
Acta Crystallographica Section E (2006) 62, 2 o780-o782
a=14.821(3)Å b=9.656(2)Å c=8.365(2)Å
α=90.00° β=92.46(3)° γ=90.00°
Diflunisal
C14.5H7F2O3
Acta Crystallographica Section E (2001) 57, 7 o604-o606
a=34.826(17)Å b=3.7296(16)Å c=20.703(10)Å
α=90.00° β=110.63(5)° γ=90.00°
Diflunisal hydrate
C13H8F2O3,H2O1
Acta Crystallographica Section E (2001) 57, 5 o477-o479
a=34.650(2)Å b=3.730(2)Å c=20.760(2)Å
α=90.00° β=110.47(6)° γ=90.00°
C13H18O2
C13H18O2
Acta Crystallographica Section E (2003) 59, 9 o1357-o1358
a=12.456(4)Å b=8.0362(11)Å c=13.533(3)Å
α=90.00° β=112.86(2)° γ=90.00°
N-(2-hydroxyphenyl)acetamide
C8H9NO2
Acta Crystallographica Section E (2006) 62, 9 o3627-o3628
a=10.5199(11)Å b=17.0195(13)Å c=4.2415(8)Å
α=90.00° β=90.00° γ=90.00°
4-Amino-N-(2,5-dichlorophenyl)benzenesulfonamide
C12H10Cl2N2O2S
Acta Crystallographica Section E (2007) 63, 3 o1526-o1528
a=12.848(2)Å b=7.2620(10)Å c=14.993(2)Å
α=90.00° β=105.720(10)° γ=90.00°
3-hydroxybenzamide
C7H7NO2
Acta Crystallographica Section E (2007) 63, 5 o2359-o2360
a=10.873(5)Å b=5.064(2)Å c=11.641(5)Å
α=90.0000° β=92.414(11)° γ=90.0000°
3-(Acetylamino)benzoic acid
C9H9NO3
Acta Crystallographica Section E (2007) 63, 5 o2361-o2361
a=3.9522(15)Å b=10.699(4)Å c=19.831(7)Å
α=90.0000° β=93.393(8)° γ=90.0000°
Pyridine-3-carbaldehyde 2-pyridylhydrazone
C11H10N4
Acta Crystallographica Section E (2007) 63, 6 o3042-o3042
a=10.896(5)Å b=4.0270(17)Å c=22.710(9)Å
α=90.0000° β=94.304(8)° γ=90.0000°
4-Amino-N-(2,3-dichlorophenyl)benzenesulfonamide
C12H10Cl2N2O2S
Acta Crystallographica Section E (2006) 62, 12 o5634-o5636
a=7.4700(8)Å b=13.6130(10)Å c=14.5480(10)Å
α=110.910(10)° β=90.510(10)° γ=102.420(10)°
4-Hydroxybenzamide
C7H7NO2
Acta Crystallographica Section E (2007) 63, 5 o2362-o2362
a=4.5828(15)Å b=8.825(3)Å c=15.888(5)Å
α=90.0000° β=90.770(7)° γ=90.0000°
Felodipine--diazabicyclo[2.2.2]octane--water (1/1/1)
C18H19Cl2NO4,C6H12N2,H2O
Acta Crystallographica Section C (2012) 68, 11 o456-o458
a=11.3003(3)Å b=13.2721(3)Å c=17.2019(4)Å
α=90.00° β=95.398(2)° γ=90.00°
2(C14H12ClNO2),C10H8N2
2(C14H12ClNO2),C10H8N2
Crystal Growth & Design (2015) 15, 1 228
a=4.7315(12)Å b=45.263(12)Å c=7.929(2)Å
α=90.00° β=106.911(3)° γ=90.00°
2(C15H15NO2),C10H8N2
2(C15H15NO2),C10H8N2
Crystal Growth & Design (2015) 15, 1 228
a=7.3302(4)Å b=8.6992(5)Å c=13.6719(8)Å
α=106.276(1)° β=99.368(1)° γ=98.738(1)°
2(C13H11NO2),C10H8N2
2(C13H11NO2),C10H8N2
Crystal Growth & Design (2015) 15, 1 228
a=7.7606(5)Å b=9.7575(6)Å c=20.0638(12)Å
α=98.2930(10)° β=92.4230(10)° γ=104.5940(10)°
2(C13H9F3N2O2),C10H8N2
2(C13H9F3N2O2),C10H8N2
Crystal Growth & Design (2015) 15, 1 228
a=26.000(4)Å b=6.7394(10)Å c=19.854(3)Å
α=90.00° β=111.386(2)° γ=90.00°